World's Best Scientists 2026 revealed!

D-Index & Metrics

Immunology

D-Index
73
Citations
15644
World Ranking
2161
National Ranking
80

Andreas Suhrbier publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Andreas Suhrbier sits on this spectrum.

62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 68 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientists 807+ publications: 100 scientists
62 publications 807+

This scientist: 278 publications — 59th percentile

59% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

Andreas Suhrbier D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Andreas Suhrbier sits on this spectrum.

40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 162 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40 D-Index 157+

This scientist: 73 D-Index — 58th percentile

58% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

Overview

Andreas Suhrbier is affiliated with the QIMR Berghofer Medical Research Institute in Australia, contributing extensively to the field of medical research with a focus on infectious diseases and related areas.

Their recent publications include works spanning from 2020 to 2022, addressing urgent topics in viral infections and immunology. Notable papers are:

  • BET inhibition blocks inflammation-induced cardiac dysfunction and SARS-CoV-2 infection, 2021, Cell
  • A versatile reverse genetics platform for SARS-CoV-2 and other positive-strand RNA viruses, 2021, Nature Communications
  • Synthetic Heparan Sulfate Mimetic Pixatimod (PG545) Potently Inhibits SARS-CoV-2 by Disrupting the Spike-ACE2 Interaction, 2022, ACS Central Science
  • Microplastic consumption induces inflammatory signatures in the colon and prolongs a viral arthritis, 2021, The Science of The Total Environment
  • Arthritogenic alphaviruses: epidemiological and clinical perspective on emerging arboviruses, 2020, The Lancet Infectious Diseases

Frequent collaborators in their research include the following scientists:

  • Kexin Yan
  • Daniel J. Rawle
  • Bing Tang
  • Cameron Bishop
  • Thuy T. Le

Their work has been published repeatedly in several scientific venues, with the most frequent being:

  • bioRxiv (Cold Spring Harbor Laboratory) with 25 publications
  • Frontiers in Immunology with 4 publications
  • PLoS Pathogens with 4 publications
  • Vaccines with 4 publications
  • Journal of Virology with 4 publications

Andreas Suhrbier's research spans broadly across medicine, with 190 publications primarily focused on infectious diseases. Key subfields include:

  • Infectious Diseases (101 publications)
  • Public Health, Environmental and Occupational Health (47 publications)
  • Molecular Biology (18 publications)
  • Immunology (13 publications)
  • Epidemiology (12 publications)

Their scientific interests cover a range of important topics, such as:

  • Mosquito-borne diseases and control
  • SARS-CoV-2 and COVID-19 Research
  • Viral Infections and Vectors
  • COVID-19 Clinical Research Studies
  • Viral Infections and Outbreaks Research
  • Long-Term Effects of COVID-19
  • Insect symbiosis and bacterial influences

Best Publications

  • Chikungunya disease in nonhuman primates involves long-term viral persistence in macrophages

    Karine Labadie;Thibaut Larcher;Christophe Joubert;Abdelkrim Mannioui

  • Arthritogenic alphaviruses—an overview

    Andreas Suhrbier;Marie-Christine Jaffar-Bandjee;Philippe Gasque

  • Chikungunya Virus Arthritis in Adult Wild-Type Mice

    Joy Gardner;Itaru Anraku;Thuy T. Le;Thibaut Larcher

  • Dominant selection of an invariant T cell antigen receptor in response to persistent infection by Epstein-Barr virus.

    Victor P. Argaet;Christopher W. Schmidt;Scott R. Burrows;Sharon L. Silins

  • Antitumor activity of 3-ingenyl angelate: plasma membrane and mitochondrial disruption and necrotic cell death.

    Steven M. Ogbourne;Andreas Suhrbier;Brad Jones;Sarah-Jane Cozzi

  • A totally synthetic vaccine of generic structure that targets Toll-like receptor 2 on dendritic cells and promotes antibody or cytotoxic T cell responses

    David C. Jackson;Yuk Fai Lau;Thuy Le;Andreas Suhrbier

  • Chikungunya Virus Nonstructural Protein 2 Inhibits Type I/II Interferon-Stimulated JAK-STAT Signaling

    Jelke J. Fros;Wen Jun Liu;Natalie A. Prow;Corinne Geertsema

  • Delivery of Multiple CD8 Cytotoxic T Cell Epitopes by DNA Vaccination

    Scott A. Thomson;Martina A. Sherritt;Jill Medveczky;Suzanne L. Elliott

  • H-2 class I knockout, HLA-A2.1-transgenic mice: a versatile animal model for preclinical evaluation of antitumor immunotherapeutic strategies

    Hüseyin Firat;Francisco Garcia-Pons;Sophie Tourdot;Steve Pascolo

  • Nanopatch-targeted skin vaccination against West Nile Virus and Chikungunya virus in mice.

    Tarl W. Prow;Xianfeng Chen;Natalie A. Prow;Germain J. P. Fernando

  • Neutrophils Are a Key Component of the Antitumor Efficacy of Topical Chemotherapy with Ingenol-3-Angelate

    Jodie M. Challacombe;Andreas Suhrbier;Peter G. Parsons;Brad Jones

  • Interferon Response Factors 3 and 7 Protect against Chikungunya Virus Hemorrhagic Fever and Shock

    Penny A. Rudd;Jane Wilson;Jane Wilson;Joy Gardner;Thibaut Larcher

  • Rheumatic manifestations of chikungunya: emerging concepts and interventions

    Andreas Suhrbier

  • BET inhibition blocks inflammation-induced cardiac dysfunction and SARS-CoV-2 infection.

    Richard J. Mills;Sean J. Humphrey;Patrick R.J. Fortuna;Mary Lor

  • Clinical and pathologic aspects of arthritis due to Ross River virus and other alphaviruses.

    Andreas Suhrbier;May La Linn

  • Minimal Epitopes Expressed in a Recombinant Polyepitope Protein are Processed and Presented to CD8^+ Cytotoxic T Cells: Implications for Vaccine Design

    Scott A. Thomson;Rajiv Khanna;Joy Gardner;Scott R. Burrows

  • Heat Shock Protein 10 Inhibits Lipopolysaccharide-induced Inflammatory Mediator Production

    Barbara J. Johnson;Thuy T.T. Le;Caroline A. Dobbin;Tatjana Banovic

  • Multiple Immune Factors Are Involved in Controlling Acute and Chronic Chikungunya Virus Infection

    Yee Suan Poo;Penny A. Rudd;Joy Gardner;Jane A. C. Wilson

  • Phase I Trial of a CD8+ T-Cell Peptide Epitope-Based Vaccine for Infectious Mononucleosis

    Suzanne L. Elliott;Andreas Suhrbier;John J. Miles;Greg Lawrence

  • Effective chikungunya virus-like particle vaccine produced in insect cells.

    Stefan W. Metz;Joy Gardner;Corinne Geertsema;Thuy T. Le

  • Recombinant polyepitope vaccines for the delivery of multiple CD8 cytotoxic T cell epitopes.

    S A Thomson;S L Elliott;M A Sherritt;K W Sproat

  • Multi-epitope DNA vaccines

    A Suhrbier

Frequent Co-Authors

Alexander A. Khromykh
Alexander A. Khromykh University of Queensland
Peter G. Parsons
Peter G. Parsons QIMR Berghofer Medical Research Institute
Denis J. Moss
Denis J. Moss QIMR Berghofer Medical Research Institute
Helder I. Nakaya
Helder I. Nakaya Universidade de São Paulo
Scott R. Burrows
Scott R. Burrows QIMR Berghofer Medical Research Institute
Suresh Mahalingam
Suresh Mahalingam Griffith University
Roy A. Hall
Roy A. Hall University of Queensland
John D. Hayball
John D. Hayball University of South Australia
Gorben P. Pijlman
Gorben P. Pijlman Wageningen University & Research
Rajiv Khanna
Rajiv Khanna QIMR Berghofer Medical Research Institute

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those interested in Immunology, branching into related fields like nursing and psychiatric care offers promising career opportunities. Many students consider programs like the easiest nurse practitioner program options to balance rigorous study with manageable workloads.

Specializing further, individuals often explore mental health through programs such as the best pmhnp programs online, valued for their excellent clinical placement rates which can facilitate hands-on experience and job readiness.

Cost is another key factor when selecting a degree. Aspiring nurse practitioners may benefit from researching the cheapest pmhnp programs that provide quality education without excessive financial burden.

After completing a Doctor of Nursing Practice (DNP) degree, graduates often want to understand earning potential. Information about how much do dnps make helps in setting realistic career goals and expectations across different states.

Exploring these online degrees and career pathways broadens the scope for immunology students, connecting their knowledge to healthcare professions with strong growth and rewarding outcomes.

Best Scientists Citing Andreas Suhrbier

Trending Scientists